I Mean this smells....why on earth would PAR be asking for more than their P1 and P2 objectives in that it involves non clinical data....it doesn't make sense!!!
"I am guessing that PAR are seeking a broader than we expected charter.If the non-clinical data is tied to either, then what is its nature, is it essential, what is its purpose, marketing material?"
I Mean this smells....why on earth would PAR be asking for more...
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
23.0¢ |
Change
-0.010(4.17%) |
Mkt cap ! $80.48M | |||
| Open | High | Low | Value | Volume |
| 25.0¢ | 25.0¢ | 22.5¢ | $167.1K | 714.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 120730 | 22.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 23.0¢ | 49999 | 1 |
View Market Depth
| Last trade - 16.10pm 18/11/2024 (20 minute delay) ? |
| PAR (ASX) Chart |